PAPER
Synthesis of the CDK-Inhibitor Paullone
3943
H, NH), 4.20 (q, J = 7.2 Hz, 2 H, OCH2), 1.44 (s, 9 H, t-Bu), 1.29
(t, J = 7.2 Hz, 3 H, CH3).
(1 d). The mixture was poured into sat. aq NaHCO3 and after addi-
tion of EtOAc, the organic layer was separated, dried (Na2SO4), and
concentrated in vacuo to furnish a colorless foam (61 mg). The
crude aniline was dissolved in dioxane (2 mL) and after addition of
AcOH (250 mL, 4.37 mmol), the mixture was stirred at 80 °C until
TLC indicated complete conversion (2 d). The mixture was parti-
tioned between sat. aq NaHCO3 and EtOAc and the organic layer
was separated, dried (Na2SO4), and concentrated in vacuo. Tritura-
tion of the residue (EtOAc–PE) furnished 11 (46 mg, 73%) as pale
yellow crystals; mp >260 °C (dec.)16
13C NMR (75.5 MHz, CDCl3): d = 166.7 (CO2Et), 153.3 (OCONH),
142.6 (C2), 138.8 (Cb), 136.4 (C2¢), 131.5, 130.6, 128.4, 128.3,
125.3, 124.7 (2C), 123.4, 121.5, 120.6, 117.1 (CN), 114.6 (C3),
81.1 [C(CH3)3], 60.6 (OCH2), 48.2 (CHN), 28.1 [C(CH3)3], 14.2
(CH3).
MS (FD): m/z (%) = 421.5 (100) [M]+.
Anal. Calcd for C24H27N3O4: C, 68.39; H, 6.46; N, 9.97. Found: C,
68.12; H, 6.43; N, 9.66.
IR (KBr): 3436 (br), 3230 (br), 2925, 1646, 1576 (sh), 1491 (sh),
1464, 1423, 1399, 743 cm–1.
(Benzylideneamino)cinnamate 10
Yellowish crystals; mp 137–138 °C.
1H NMR (300 MHz, DMSO-d6): d = 11.59 (br s, 1 H, indole-NH),
10.10 (br s, 1 H, amide-NH), 7.74 (dd, J = 7.7, 1.6 Hz, 1 H), 7.66
(br d, J = 7.7 Hz, 1 H), 7.44 (dt, Jd = 8.0 Hz, Jt = 0.9 Hz, 1 H), 7.37
(ddd, J = 8.0, 7.4, 1.6 Hz, 1 H), 7.24–7.30 (m, 2 H), 7.17 (ddd,
J = 8.1, 7.0, 1.2 Hz, 1 H), 7.07 (ddd, J = 8.0, 7.0, 1.0 Hz, 1 H), 3.50
(br s, 2 H, CH2).
13C NMR (75.5 MHz, DMSO-d6): d = 171.6 (C6), 137.4, 135.4,
132.5 (C4a, C11a, C12a), 128.0, 126.9 (C1, C3), 126.6 (C7b), 123.7
(C2), 122.9 (C12b), 122.3, 122.1, 119.1, 118.0 (C4, C8, C9, C10),
111.5 (C11), 107.6 (C7a), 31.6 (C7).
IR (KBr): 3424 (br), 2982, 1722, 1708, 1632, 1619, 1583, 1531,
1481, 1540, 1366, 1317, 1272, 1245, 1197, 1179, 1159, 1161, 1030
(sh), 771, 760 cm–1.
1H NMR (300 MHz, CDCl3): d = 11.85 (br s, 1 H, NH), 8.52 (d,
J = 8.3 Hz, 1 H), 8.46 (s, 1 H, CH=N), 8.14 (d, J = 16.0 Hz, 1 H,
Hb), 7.65 (dd, J = 7.7, 1.5 Hz, 1 H), 7.41–7.50 (m, 3 H), 7.29 (pseu-
do t, J = 7.6 Hz, 1 H), 7.00–7.10 (m, 2 H), 6.46 (d, J = 16.0 Hz, 1 H,
Ha), 4.25 (q, J = 7.1 Hz, 2 H, OCH2), 1.51 (s, 9 H, t-Bu), 1.31 (t,
J = 7.1 Hz, 3 H, CH3).
13C NMR (75.5 MHz, CDCl3): d = 166.6 (CO2Et), 163.9 (CH=N),
153.3 (OCONH), 149.8 (C2), 141.4 (C2¢), 140.7 (Cb), 134.6, 132.9,
131.2, 128.7 (C1), 127.5, 126.5, 121.2, 120.1, 120.0 (C1¢), 119.2,
118.0, 80.2 [C(CH3)3], 60.4 (OCH2), 28.1 [C(CH3)3], 14.3 (CH3).
MS (FD): m/z (%) = 248.1 (100) [M]+.
HRMS (ESI): m/z [M + Na]+ calcd for C16H12NaN2O: 271.0847;
found: 271.0858.
MS (FD): m/z (%) = 394.5 (100) [M]+.
Acknowledgment
Anal. Calcd for C23H26N2O4: C, 70.03; H, 6.64; N, 7.10. Found: C,
69.79; H, 6.49; N, 6.98.
This work was supported by the Deutsche Forschungsgemeinschaft.
We thank H. Kolshorn (Mainz) for the NMR spectroscopic analyses
and Dr. N. Hanold (Mainz) for mass spectrometry.
Ethyl {2-[2-(tert-Butoxycarbonylamino)phenyl]-1H-indol-3-
yl}acetate (9)
To a soln of 8 (300 mg, 712 mmol) in anhyd EtOH (6 mL) was added
KOt-Bu (88 mg, 784 mmol) and the soln was stirred at r.t. for 30
min. The mixture was partitioned between sat. aq NaHCO3 and
CH2Cl2, the organic layer was dried (Na2SO4) and concentrated in
vacuo to furnish an orange foam (279 mg). Flash chromatography
(silica gel, PE–t-BuOMe, 20:1) furnished 9 (209 mg, 74%) as col-
orless crystals; mp 113–115 °C. Imine 10 (47 mg, 17%) was also
obtained.
References
(1) Meyer, N.; Opatz, T. Synlett 2003, 1427.
(2) Meyer, N.; Werner, F.; Opatz, T. Synthesis 2005, 945.
(3) Kison, C.; Meyer, N.; Opatz, T. Angew. Chem. Int. Ed. 2005,
44, 5662; Angew. Chem. 2005, 117, 5807.
(4) Bergner, I.; Opatz, T. Synthesis 2007, 918.
(5) von Miller, W.; Plöchl, J. Ber. Dtsch. Chem. Ges. 1898, 31,
2718.
IR (KBr): 3405 (br), 2980, 2933, 1730 (sh), 1586, 1519, 1461, 1446,
1393, 1369, 1300, 1242, 1158 (sh), 1049, 1027, 766, 745 cm–1.
(6) Walia, J. S.; Heindl, L.; Lader, H.; Walia, P. S. Chem. Ind.
(London) 1968, 155.
1H NMR (300 MHz, CDCl3): d = 8.32 (br s, 1 H, indole-NH), 8.16
(d, J = 8.3 Hz, 1 H), 7.66 (d, J = 8.3 Hz, 1 H), 7.37–7.45 (m, 2 H),
7.34 (dd, J = 7.5, 1.7 Hz, 1 H), 7.17–7.31 (m, 2 H), 7.12 (pseudo t,
J = 7.5 Hz, 1 H), 6.93 (br s, 1 H, NHBoc), 4.12 (q, J = 7.1 Hz, 2 H,
OCH2), 3.63 (s, 2 H, CH2CO), 1.46 (s, 9 H, t-Bu), 1.22 (t, J = 7.1
Hz, 3 H, CH3).
13C NMR (75.5 MHz, CDCl3): d = 171.8 (CO), 153.2 (C2¢), 137.3,
136.1, 132.3 (C2, C2¢, C7a), 131.3 (CH), 129.9 (CH), 128.1, 122.9
(CH), 122.6 (CH), 121.6, 120.2 (CH), 119.1 (CH), 111.2 (C7),
108.0 (C3), 80.7 [C(CH3)3], 60.8 (OCH2), 30.7 (ArCH2), 28.2
[C(CH3)3], 14.1 (CH3).
(7) Opatz, T.; Ferenc, D. Org. Lett. 2006, 8, 4473.
(8) Kunick, C. Arch. Pharm. (Weinheim, Ger.) 1992, 325, 297.
(9) Schultz, C.; Link, A.; Leost, M.; Zaharevitz, D. W.; Gussio,
R.; Sausville, E. A.; Meijer, L.; Kunick, C. J. Med. Chem.
1999, 42, 2909.
(10) Kunick, C.; Lauenroth, K.; Wieking, K.; Xie, X.; Schultz,
C.; Gussio, R.; Zaharevitz, D.; Leost, M.; Meijer, L.; Weber,
A.; Jorgensen, F. S.; Lemcke, T. J. Med. Chem. 2004, 47, 22.
(11) Pies, T.; Schaper, K.-J.; Leost, M.; Zaharevitz, D. W.;
Gussio, R.; Meijer, L.; Kunick, C. Arch. Pharm. (Weinheim,
Ger.) 2004, 337, 486.
(12) Lahusen, T.; De Siervi, A.; Kunick, C.; Senderowicz, A. M.
MS (FD): m/z (%) = 394.5 (100) [M]+.
Mol. Carcinog. 2003, 36, 183.
(13) Kamb, A. Curr. Top. Microbiol. Immunol. 1998, 227, 139.
(14) Kunick, C.; Zeng, Z.; Gussio, R.; Zaharevitz, D.; Leost, M.;
Totzke, F.; Schaechtele, C.; Kubbutat, M. H. G.; Meijer, L.;
Lemcke, T. ChemBioChem 2005, 6, 541.
(15) Baudoin, O.; Cesario, M.; Guenard, D.; Gueritte, F. J. Org.
Chem. 2002, 67, 1199.
(16) Joucla, L.; Popowycz, F.; Lozach, O.; Meijer, L.; Joseph, B.
Helv. Chim. Acta 2007, 90, 753.
(17) Bremner, J. B.; Sengpracha, W. Tetrahedron 2005, 61, 5489.
Anal. Calcd for C23H26N2O4: C, 70.03; H, 6.64; N, 7.10. Found: C,
69.97; H, 6.66; N, 7.08.
Paullone [7,12-Dihydroindolo[3,2-d][1]benzazepin-6(5H)-one,
11]8
To a soln of 9 (100 mg, 254 mmol) in anhyd CH2Cl2 (2 mL) was add-
ed EtSMe (229 mL, 2.54 mmol) and TFA (195 mL, 2.54 mmol) and
the soln was stirred at r.t. until TLC indicated complete conversion
Synthesis 2008, No. 24, 3941–3944 © Thieme Stuttgart · New York